期刊文献+

重组原核表达载体pGEX-4T-1-MAGE-1的构建及表达 被引量:1

Establishment and expression of recombinant prokaryotic vector pGEX-4T-1-MAGE-1
下载PDF
导出
摘要 目的:构建人肿瘤相关抗原MAGE1基因原核表达载体。方法:从人肝细胞性肝癌组织中提取总RNA,RT- PCR扩增出MAGE1基因。酶切鉴定后,将其插入pGEM T载体,再克隆至原核表达载体pGEX4T-1中,构建重组表达质粒pGEX4T-1MAGE-1。将重组质粒转化大肠杆菌BL21(DE3),经1mmol/L异丙基βD硫代半乳糖苷(IPTG)诱导4h,SDS PAGE及凝胶密度扫描分析目的蛋白的表达情况。结果:RT-PCR扩增出长度为927bp的MAGE1基因。重组表达质粒pGEX4T1MAGE1转化大肠杆菌BL21(DE3)后经诱导表达,目的蛋白约57000,占菌体总蛋白的23%。结论:成功构建出重组原核表达载体pGEX4T-1MAGE-1,该载体在大肠杆菌BL21(DE3)中高效表达。 Aim: To establish recombinant prokaryotic vector of MAGE-1 gene. Methods:The mRNA of MAGE-1 gene was isolated from HCC tissue, and the cDNA was amplified by RT-PCR. After cloning with pGEM-T vector and sequencing, the MAGE-1 gene was inserted into the prokaryotic express vector pGEX-4T-1. BL21 (DE3) was transformed with the recombinant pGEX-4T-1-MAGE-1, and was induced by IPTG for 4 h,and then the fusion MAGE-1 protein was detected using SDS-PAGE and Western-blot method. Results: A 927 bp MAGE-1 gene was obtained by RT-PCR. SDS-PAGE indicated that the expressed protein was about 57 000 and account for 23% of the total bacterial proteins. Conclusion : Recombinant prokaryotic vector pGEX-4T-1-MAGE-1 is established successfully and can be highly expressed in BL21 (DE3).
出处 《郑州大学学报(医学版)》 CAS 北大核心 2006年第3期491-494,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省医学科技创新人才工程基金资助项目20043008
关键词 MAGE-1 PGEX-4T-1 表达载体 原核表达 融合蛋白 MAGE-1 pGEX-4T-1 expressive vector prokaryotic expression fusion protein
  • 相关文献

参考文献4

  • 1Eura M,Ogi K,Chikamatsu K,et al.Expression of the MAGE gene family in human head and neck squamous-cell carcinomas.Int J Cancer,1995,64(5):304
  • 2Takahashi K,Shichijo S,Noguchi M,et al.Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis.Cancer Res,1995,55 (16):3 478
  • 3Yamada A,Kataoda A,Shichijo S,et al.Expression of Mage-1,MAGE-2,MAGE-3/-6 and MAGE-4a/4b gene in ovarian tumors.Int J Cancer,1995,64(6):388
  • 4Chaux P,Luiten R,Demotte N,et al.Identification of five MAGE-A1 epitopes recognized by cytolytic T Lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1.J Immunol,1999,163 (5):2 928

同被引文献13

  • 1李郑武,曲洪琴,朱绿松,李会成,王晴,伞德忠.肿瘤生物治疗药物研究进展[J].中国药业,2005,14(3):75-76. 被引量:3
  • 2厉保秋,杨志坚,Takayaki,朱振平,于丽华.猕猴静注重组蛋氨酸酶后的药代动力学、免疫原性及系统毒性[J].毒理学杂志,2005,19(A03):278-278. 被引量:2
  • 3程太平,荣俊,刘晓娜,邹浩勇,齐晓亮,樊友净.IBDV VP2基因重组质粒pBV220表达条件的优化[J].动物医学进展,2007,28(4):9-13. 被引量:3
  • 4李鸿钧,王文举,施锐,张光明,李敏,马雁冰,孙茂盛.人鼻病毒3C蛋白酶基因的克隆、表达、纯化及活性[J].中国生物制品学杂志,2007,20(4):240-243. 被引量:5
  • 5LUCA RONDA,NATALIA P. Bazhulina.Exploring meth- ionine 3,-lyase structure-function relationship via microspetrophotomertry and X-ray crystallography [J]. Biochimica et Biophysic Acta, 2011,1814:834 - 842.
  • 6CELLARIER E,DURANDO X,VASSON M P,et al. Methionine dependency and cancer treatment [J]. Cancer Treat Rev, 2003,29(6) : 489 - 499.
  • 7YAMAMOTO N, GUPTA A, XUM, et al. Methioninase gene therapy with selenom ethionine induces apoptosis in bcl-2-overproducing lung cancer cells [J]. Cancer Gene Ther,2003,10(6) :445 - 450.
  • 8BENJAMIN DIAS,BART WEIMER. Purification and characterization of L-Methionine γ-Lyase from Brevibacteri- um linens BL2[J]. Applied and Environmental Microbiology, 1998, (64)9:3 327 - 3 331.
  • 9TOMOAKI TAKAKURA,KENJI MITSUSHIMA,SHIGEO YAGI,et al. Assay method for antitumor L-methionine 3'-lyase: comprehensive kinetic analysis of the complex reaction with L-methionine [J]. Analytical Biochemistry, 2004,327(2) : 233 - 240.
  • 10YAMAMOTO N,GUPTA A,XU M,et al. Methioninase gene therapy with selenomcthionine induces apoptosis in hcl-2-overproducing lung cancer cells [J]. Cancer Gene Ther, 2003,10:445 - 450.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部